Why Emeritus Corporation and Isis Pharmaceuticals, Inc Won Huge Today

Two big winners in the health-care space today were Emeritus Corp (NYSE: ESC  ) and Isis Pharmaceuticals (NASDAQ: ISIS  ) . In this video from Friday's Market Checkup, Motley Fool health-care analyst David Williamson takes a look at what caused shares to pop.

Seattle-based Emeritus saw shares shoot up more than 35% today on the news that it had agreed to be bought out by Brookdale Senior Living (NYSE: BKD  ) . The combined company will have a presence in 46 states and, with more than1100 facilities, will have a 10% market share. Due to reimbursement cuts from Medicare, scale is vital in this industry, so this could be a very beneficial deal. However, David mentions some caveats that investors will want to keep in mind. He suggests a "wait and see" strategy here, to see if these companies are, in fact, better together than apart.

Also, Isis Pharmaceuticals shot up 15% today after the orphan drugmaker reported positive phase 2 trial results for its drug focused on the rare spinal disorder spinal muscular atrophy. While some analysts have been calling this a potential blockbuster, David tempers enthusiasm, saying it's probably still a bit too early to be making that call. However, he does call attention to the company's partnership strategy and vast number of pipeline assets as indicators that this is definitely more than a one-trick pony, and certainly a company to watch.

Looking for more ways to play the biotech space?
The best way to play the biotech space is to find companies that shun the status quo and, instead, discover revolutionary, groundbreaking technologies. In the Motley Fool's brand-new FREE report, "2 Game-Changing Biotechs Revolutionizing the Way We Treat Cancer," find out about a new technology that big pharma is endorsing through partnerships, and the two companies that are set to profit from this emerging drug class. Click here to get your copy today.


Read/Post Comments (1) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On February 21, 2014, at 11:32 PM, Ostrowsr wrote:

    ISIS is indeed a growing company. I liked it at $6.00 and like it today at $60. Voted in the 90s to be the new ground breaking company with a unique model. Patents, many drugs in the pipeline, deals with big companies, royalties. Much potential.

Add your comment.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2849797, ~/Articles/ArticleHandler.aspx, 12/20/2014 3:13:49 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement